secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2021-11-24T23:59:59+00:00
Accession:  0001193125-21-339389
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Teva appoints Amir Weiss as Chief Accounting Officer, replacing Andrew Weil
---------------------------------------------------------------------------

- Andrew Weil steps down as Chief Accounting Officer effective November 24, 2021.
- Amir Weiss promoted from VP Finance and Corporate Controller to SVP and Chief Accounting Officer, effective same date.
- Weiss's base salary increased to 840,000 NIS; eligible for 50% target annual cash incentive and equity awards.
- Weiss joined Teva in 2012 and holds an MA in law, MBA, and CPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/0001193125-21-339389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/d222550d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-339389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer